Index RUT
P/E 187.72
EPS (ttm) 0.11
Insider Own 45.73%
Shs Outstand 70.94M
Perf Week 8.60%
Market Cap 1.44B
Forward P/E 34.46
EPS next Y 0.59
Insider Trans -0.60%
Shs Float 38.50M
Perf Month 14.99%
Income 8.65M
PEG -
EPS next Q 0.01
Inst Own 50.00%
Short Float 9.46%
Perf Quarter 9.95%
Sales 301.77M
P/S 4.78
EPS this Y -157.23%
Inst Trans -0.13%
Short Ratio 9.29
Perf Half Y 25.49%
Book/sh 6.50
P/B 3.13
EPS next Y 615.48%
ROA 1.80%
Short Interest 3.64M
Perf Year 48.50%
Cash/sh 3.01
P/C 6.75
EPS next 5Y -
ROE 2.10%
52W Range 12.94 - 22.09
Perf YTD 15.91%
Dividend Est. -
P/FCF 67.52
EPS past 5Y -
ROI 1.96%
52W High -7.97%
Beta 0.34
Dividend TTM -
Quick Ratio 3.79
Sales past 5Y 98.80%
Gross Margin 64.07%
52W Low 57.11%
ATR (14) 0.66
Dividend Ex-Date -
Current Ratio 4.21
EPS Y/Y TTM -95.59%
Oper. Margin -10.12%
RSI (14) 70.59
Volatility 3.44% 3.37%
Employees 297
Debt/Eq 0.03
Sales Y/Y TTM 27.69%
Profit Margin 2.87%
Recom 1.00
Target Price 30.67
Option/Short Yes / Yes
LT Debt/Eq 0.02
EPS Q/Q -42.47%
Payout 0.00%
Rel Volume 0.76
Prev Close 19.99
Sales Surprise 3.80%
EPS Surprise -204.51%
Sales Q/Q 65.18%
Earnings Apr 23 BMO
Avg Volume 392.08K
Price 20.33
SMA20 12.93%
SMA50 6.09%
SMA200 13.87%
Trades
Volume 296,938
Change 1.70%
Date
Action
Analyst
Rating Change
Price Target Change
May-03-24 Initiated
Wells Fargo
Overweight
$34
Jun-29-20 Reiterated
BofA Securities
Buy
$25 → $40
Apr-01-20 Initiated
BofA/Merrill
Buy
$25
Mar-11-19 Initiated
Barclays
Overweight
$26
Dec-12-18 Reiterated
Wedbush
Outperform
$31 → $33
Jun-19-18 Initiated
JMP Securities
Mkt Outperform
$33
May-07-24 04:01PM
Apr-24-24 09:00AM
Apr-23-24 11:53AM
08:53AM
08:40AM
08:36AM
Loading…
08:36AM
07:30AM
Apr-16-24 04:01PM
Apr-02-24 07:30AM
Mar-01-24 09:55AM
Feb-29-24 11:33PM
12:00PM
09:21AM
Feb-28-24 08:50AM
08:40AM
07:52AM
Loading…
07:52AM
07:30AM
Feb-21-24 04:01PM
Feb-12-24 09:55AM
08:50AM
Jan-23-24 09:55AM
08:50AM
Jan-09-24 08:46AM
Jan-04-24 07:30AM
Jan-02-24 04:01PM
Dec-23-23 09:00AM
Dec-15-23 02:30PM
Nov-24-23 02:05PM
Nov-20-23 09:55AM
Nov-09-23 10:01PM
08:27AM
Loading…
Nov-01-23 08:27AM
Oct-31-23 10:48PM
(Thomson Reuters StreetEvents)
08:50AM
07:30AM
Oct-24-23 04:01PM
Oct-20-23 12:08PM
Sep-29-23 12:43PM
Aug-27-23 08:40AM
Aug-22-23 08:14AM
Aug-18-23 09:04PM
Aug-10-23 10:33PM
Aug-07-23 06:14AM
Jul-25-23 10:05PM
(Thomson Reuters StreetEvents) +30.39%
01:06PM
08:45AM
07:30AM
Jul-24-23 08:31AM
Jul-18-23 04:01PM
Jul-17-23 08:00AM
Jul-04-23 08:24PM
Jun-06-23 04:01PM
May-03-23 06:14AM
May-02-23 08:45AM
07:30AM
May-01-23 04:01PM
Apr-09-23 09:21AM
Apr-05-23 01:40PM
Mar-31-23 09:35AM
Mar-30-23 02:20PM
Mar-29-23 10:13AM
Mar-27-23 12:04PM
Mar-23-23 02:25PM
Mar-03-23 06:57PM
Feb-28-23 11:25AM
08:00AM
Feb-27-23 04:01PM
11:47AM
Feb-23-23 10:50AM
Jan-25-23 02:52AM
Jan-21-23 04:51PM
Jan-09-23 08:00AM
Jan-03-23 04:01PM
Nov-30-22 04:01PM
Nov-23-22 04:01PM
Nov-10-22 09:40AM
Nov-07-22 09:55AM
08:50AM
Nov-01-22 09:15AM
08:00AM
Oct-31-22 04:01PM
Oct-24-22 09:40AM
Oct-05-22 08:50AM
Sep-21-22 12:00PM
Sep-20-22 10:30AM
Sep-12-22 08:30AM
Aug-22-22 09:55AM
Aug-05-22 09:55AM
Aug-04-22 09:09AM
Aug-03-22 04:01PM
09:40AM
08:45AM
08:30AM
(Thomson Reuters StreetEvents)
07:30AM
07:29AM
Aug-02-22 04:01PM
Jul-22-22 12:00PM
Jun-22-22 09:14AM
Jun-19-22 09:49AM
May-05-22 06:52AM
May-03-22 09:15AM
Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, Vixarelimab, and KPL-404. The company was founded by Sanj K. Patel, Stephen Frank Mahoney, Krisha S. Mahoney, Thomas W. Beetham, Christopher Heberlig, Carsten Boess, Rasmus Holm-Jorgensen, Gregory Alex Grabowksi, Aaron Isadore Young, Eben P. Tessari, Jennifer Lynne Mason and Mickenzie Elizabeth Gallagher in July 2015 and is headquartered in Lexington, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Patel Sanj K CHAIRMAN & CEO Mar 07 '24 Sale 21.02 65,012 1,366,552 0 Mar 11 07:05 PM Patel Sanj K CHAIRMAN & CEO Mar 06 '24 Sale 21.00 5,582 117,222 65,012 Mar 06 05:37 PM Patel Sanj K CHAIRMAN & CEO Mar 04 '24 Sale 21.49 12,742 273,834 70,594 Mar 06 05:37 PM Megna Michael R CHIEF ACCOUNTING OFFICER Mar 01 '24 Option Exercise 10.93 9,659 105,560 27,247 Mar 01 06:26 PM Paolini John F. CHIEF MEDICAL OFFICER Mar 01 '24 Option Exercise 1.86 18,844 35,050 62,736 Mar 05 04:31 PM Tessari Eben CHIEF OPERATING OFFICER Mar 01 '24 Option Exercise 1.59 656 1,043 124,036 Mar 05 04:34 PM Paolini John F. CHIEF MEDICAL OFFICER Mar 01 '24 Sale 21.77 18,844 410,234 44,892 Mar 05 04:31 PM Megna Michael R CHIEF ACCOUNTING OFFICER Mar 01 '24 Sale 21.45 9,659 207,186 17,588 Mar 01 06:26 PM Tessari Eben CHIEF OPERATING OFFICER Mar 01 '24 Sale 22.03 1,189 26,194 122,847 Mar 05 04:34 PM Megna Michael R CHIEF ACCOUNTING OFFICER Feb 28 '24 Option Exercise 8.83 5,126 45,263 22,714 Mar 01 06:26 PM Megna Michael R CHIEF ACCOUNTING OFFICER Feb 28 '24 Sale 21.79 5,126 111,696 17,588 Mar 01 06:26 PM Paolini John F. CHIEF MEDICAL OFFICER Feb 27 '24 Option Exercise 1.86 10,156 18,890 55,048 Feb 29 04:26 PM Paolini John F. CHIEF MEDICAL OFFICER Feb 27 '24 Sale 21.03 10,156 213,581 44,892 Feb 29 04:26 PM Ragosa Mark CHIEF FINANCIAL OFFICER Jan 03 '24 Option Exercise 8.83 12,000 105,960 27,632 Jan 04 04:30 PM Ragosa Mark CHIEF FINANCIAL OFFICER Jan 03 '24 Sale 20.00 12,000 240,000 15,632 Jan 04 04:30 PM Megna Michael R CHIEF ACCOUNTING OFFICER Jan 02 '24 Option Exercise 13.88 16,670 231,380 33,675 Jan 04 04:30 PM Megna Michael R CHIEF ACCOUNTING OFFICER Jan 02 '24 Sale 19.17 16,670 319,564 17,005 Jan 04 04:30 PM Megna Michael R CHIEF ACCOUNTING OFFICER Dec 19 '23 Option Exercise 13.88 9,316 129,306 26,321 Dec 21 04:26 PM Megna Michael R CHIEF ACCOUNTING OFFICER Dec 19 '23 Sale 19.13 9,316 178,215 17,005 Dec 21 04:26 PM Paolini John F. CHIEF MEDICAL OFFICER Dec 07 '23 Option Exercise 1.86 28,600 53,196 73,492 Dec 11 04:20 PM Paolini John F. CHIEF MEDICAL OFFICER Dec 07 '23 Sale 17.65 28,600 504,758 44,892 Dec 11 04:20 PM Paolini John F. CHIEF MEDICAL OFFICER Sep 05 '23 Option Exercise 1.86 400 744 45,292 Sep 06 07:03 PM Paolini John F. CHIEF MEDICAL OFFICER Sep 05 '23 Sale 17.53 400 7,012 44,892 Sep 06 07:03 PM Paolini John F. CHIEF MEDICAL OFFICER Jul 25 '23 Option Exercise 1.86 29,000 53,940 70,910 Jul 27 04:30 PM Paolini John F. CHIEF MEDICAL OFFICER Jul 25 '23 Sale 19.14 29,000 555,160 41,910 Jul 27 04:30 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite